José Luis Sandoval
@jlsandoval.bsky.social
MD, PhD, MPH
Oncologist @Institut Curie and @Geneva University Hospitals
Amateur photographer and bass player.
Oncologist @Institut Curie and @Geneva University Hospitals
Amateur photographer and bass player.
🧬 A study published in Nature highlights how the menstrual cycle 🩸 may influence tumor progression and the efficacy of chemotherapy 💊 in ER+ and ER- breast cancers. Further research is needed to understand the potential impact on treatment approaches. 🔬
@nkinl.bsky.social @marleenkok.bsky.social
@nkinl.bsky.social @marleenkok.bsky.social
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy - Nature
In three mouse models of breast cancer, we show reduced responses to neoadjuvant chemotherapy when treatment is initiated during the dioestrus stage, when compared with initiation during the oestrus s...
www.nature.com
December 6, 2024 at 3:43 PM
🧬 A study published in Nature highlights how the menstrual cycle 🩸 may influence tumor progression and the efficacy of chemotherapy 💊 in ER+ and ER- breast cancers. Further research is needed to understand the potential impact on treatment approaches. 🔬
@nkinl.bsky.social @marleenkok.bsky.social
@nkinl.bsky.social @marleenkok.bsky.social
The SONIA trial is out in Nature! This sequence study suggests:
🌀 Not all patients w/ HR+/HER2- mBC need CDK4/6i in 1L.
✅ Delaying CDK4/6i achieves similar long-term outcomes with:
• Lower costs 💰
• Less toxicity ⚠️
• No loss in QoL.
The debate is far from over, but can’t be ignored.
🌀 Not all patients w/ HR+/HER2- mBC need CDK4/6i in 1L.
✅ Delaying CDK4/6i achieves similar long-term outcomes with:
• Lower costs 💰
• Less toxicity ⚠️
• No loss in QoL.
The debate is far from over, but can’t be ignored.
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer - Nature
The phase 3 SONIA trial challenges the benefits of using cyclin-dependent kinase 4 and 6 inhibitors as a first-line compared with second-line treatment.
www.nature.com
December 6, 2024 at 3:36 PM
The SONIA trial is out in Nature! This sequence study suggests:
🌀 Not all patients w/ HR+/HER2- mBC need CDK4/6i in 1L.
✅ Delaying CDK4/6i achieves similar long-term outcomes with:
• Lower costs 💰
• Less toxicity ⚠️
• No loss in QoL.
The debate is far from over, but can’t be ignored.
🌀 Not all patients w/ HR+/HER2- mBC need CDK4/6i in 1L.
✅ Delaying CDK4/6i achieves similar long-term outcomes with:
• Lower costs 💰
• Less toxicity ⚠️
• No loss in QoL.
The debate is far from over, but can’t be ignored.
After some time away (disgusted by the cesspool of hate speech over there), I’m giving this platform a try.
Posts will focus on Medicine, Oncology—and maybe some Art and Politics too.
Let’s see how this goes…
Posts will focus on Medicine, Oncology—and maybe some Art and Politics too.
Let’s see how this goes…
December 6, 2024 at 1:34 PM
After some time away (disgusted by the cesspool of hate speech over there), I’m giving this platform a try.
Posts will focus on Medicine, Oncology—and maybe some Art and Politics too.
Let’s see how this goes…
Posts will focus on Medicine, Oncology—and maybe some Art and Politics too.
Let’s see how this goes…
The world needs more Jobim
November 21, 2024 at 8:46 PM
The world needs more Jobim
Reposted by José Luis Sandoval
Ainda há pouco tempo vi certas e determinadas pessoas a pedir uma boa lista de serviços informativos oficiais.
Alguém teve o trabalho de criar um starter pack.
Enjoy!
Alguém teve o trabalho de criar um starter pack.
Enjoy!
November 17, 2024 at 7:52 PM
Ainda há pouco tempo vi certas e determinadas pessoas a pedir uma boa lista de serviços informativos oficiais.
Alguém teve o trabalho de criar um starter pack.
Enjoy!
Alguém teve o trabalho de criar um starter pack.
Enjoy!
Mood of the day
August 14, 2024 at 4:32 PM
Mood of the day
A clear description of the challenges faced by patients and doctors when dealing with stigma and outdated policies.
"When policies are built on fallacy rather than reflecting patients' and clinicians' needs, policy must evolve along with the evidence."
www.nejm.org/doi/full/10....
"When policies are built on fallacy rather than reflecting patients' and clinicians' needs, policy must evolve along with the evidence."
www.nejm.org/doi/full/10....
December 1, 2023 at 10:02 AM
A clear description of the challenges faced by patients and doctors when dealing with stigma and outdated policies.
"When policies are built on fallacy rather than reflecting patients' and clinicians' needs, policy must evolve along with the evidence."
www.nejm.org/doi/full/10....
"When policies are built on fallacy rather than reflecting patients' and clinicians' needs, policy must evolve along with the evidence."
www.nejm.org/doi/full/10....